ALLIGATOR BIOSCIENCE AB has a total of 193 patent applications. It decreased the IP activity by 62.0%. Its first patent ever was published in 1998. It filed its patents most often in United Kingdom, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are SHANGHAI BIOMABS PHARMACEUTICALS CO LTD, PDL BIOPHARMA INC and SYNOVEX CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 31 | |
#2 | United States | 26 | |
#3 | EPO (European Patent Office) | 25 | |
#4 | WIPO (World Intellectual Property Organization) | 25 | |
#5 | Australia | 16 | |
#6 | Canada | 15 | |
#7 | China | 13 | |
#8 | Brazil | 8 | |
#9 | Republic of Korea | 7 | |
#10 | Mexico | 6 | |
#11 | Israel | 5 | |
#12 | Denmark | 2 | |
#13 | Philippines | 2 | |
#14 | Singapore | 2 | |
#15 | Chile | 1 | |
#16 | Costa Rica | 1 | |
#17 | Ecuador | 1 | |
#18 | Hungary | 1 | |
#19 | Japan | 1 | |
#20 | Nicaragua | 1 | |
#21 | Peru | 1 | |
#22 | Serbia | 1 | |
#23 | El Salvador | 1 | |
#24 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Measuring microorganism processes | |
#7 | Fermentation | |
#8 | Combinatorial chemistry | |
#9 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Ellmark Peter | 89 |
#2 | Furebring Christina | 84 |
#3 | Norlen Per | 42 |
#4 | Fritzell Sara | 36 |
#5 | Veitonmaki Niina | 32 |
#6 | Veitonmäki Niina | 26 |
#7 | Von Schantz Laura | 22 |
#8 | Christina Furebring | 19 |
#9 | Petersson Jessica | 19 |
#10 | Varas Laura | 18 |
Publication | Filing date | Title |
---|---|---|
GB202004677D0 | Methods and compositions | |
WO2020127376A2 | Polypeptides | |
WO2020127374A2 | Polypeptides | |
GB201917066D0 | Methods and compositions | |
GB201910016D0 | Novel polypeptides | |
GB201910014D0 | Novel polypeptides | |
GB201905467D0 | Novel polypeptides | |
GB201905458D0 | Novel polypeptides | |
GB201820556D0 | Novel polypeptides | |
AU2018304585A1 | Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methods | |
KR20200002889A | Bispecific Antibodies Against OX40 and CTLA-4 | |
GB201805873D0 | Novel polypeptides | |
GB201717958D0 | Novel polypeptides | |
GB201706915D0 | Novel polypeptides | |
CN109195994A | For the novel bispecific polypeptide of CD137 | |
GB201619652D0 | Novel polypeptides | |
GB201619648D0 | Novel antibodies and uses thereof | |
GB201611530D0 | Novel polypeptides | |
EP3298045A1 | Novel polypeptides | |
GB201514994D0 | Bispecific polypeptide |